Taiwan News6 天
Nuance Pharma Announces Approval of Ohtuvayre™ (ensifentrine) in Macau SAR, China
In Nov 2024, Nuance Pharma launched Ohtuvayre™ in China's Hainan Boao Pilot Zone through early access program. In Sep 2024, Nuance Pharma completed recruitment for ENHANCE- CHINA, the phase 3 clinical ...